ICLR

ICON plc
D

ICLR

187.080
USD
-7.92
(-4.06%)
مغلق
حجم التداول
66,826
الربح لكل سهم
14
العائد الربحي
-
P/E
19
حجم السوق
14,549,610,080
أصول ذات صلة
NEOUSD
NEOUSD
0.03017
(0.45%)
6.61404 USD
B
BIO
1.99
(0.76%)
263.91 USD
C
CRL
-0.340
(-0.19%)
176.950 USD
DGX
DGX
-3.520
(-2.05%)
168.460 USD
ILMN
ILMN
1.730
(1.61%)
109.330 USD
LH
LH
-2.48
(-0.93%)
264.80 USD
MTD
MTD
1.66
(0.13%)
1,264.50 USD
N
NEO
-0.12500
(-1.95%)
6.29000 USD
Q
QDEL
1.050
(3.99%)
27.390 USD
TMO
TMO
3.25
(0.68%)
478.43 USD
WST
WST
-15.66
(-5.61%)
263.44 USD
المزيد
الأخبار المقالات

العنوان: ICON plc

القطاع: Healthcare
الصناعة: Diagnostics & Research
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.